Error
xxx
Welcome to the European Forum for Good Clinical Practice
Activities  >  Events and Activities  >  Adding Brexit into the pandemic mix – clinical trials to continue...
Webinar
Adding Brexit into the pandemic mix – clinical trials to continue...
Quality and ethics experts respond to your questions from sponsor and site points of view.
23 November 2020 - 17:00-18:00 CESTAdd to calendar
Description
Description

Our Free of Charge weekly Q&A Webinars on Clinical Trials During the Corona Virus Pandemic are continuing!
Quality and ethics experts respond to your questions from sponsor and site points of view.

    Adding Brexit into the pandemic mix – clinical trials to continue...

    Moderator: Mark Poulton, Poulton Quality Solutions

    Agenda:
  • Updates on the MHRA guidelines and requirements post-BREXIT for clinical trials and drug safety
  • Perspective from a Subject Matter Expert - the EU QPPV
  • An opportunity to share questions and points to consider on BREXIT and the pandemic in parallel
  • Q&A, Discussions

  • Presenters:
  • Louise Mawer, Mirabilitas Ltd
  • Sarah Hall, Mipsol

  • Panel:
  • Heather Sampson, University of Toronto
  • Hugh Davies, Oxford A Research Ethics Committee

  • It is important to ask your Questions Upfront so that the team can answer adequately, please submit your questions using the following link: Click Here


Ask us
If you have any question, send us an email to info@efgcp.eu
Follow us
Linkedin
Twitter
EFGCP
European Forum for Good Clinical Practice
Rue de Washington 40
B-1050 Brussels - Belgium
Tel : +32 2 732 87 83
TVA : BE 0457 666 685